Stay updated with breaking news from Robertm Plenge. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Avantax Planning Partners Inc. trimmed its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 13.2% in the second quarter, Holdings Channel.com reports. The firm owned 8,545 shares of the biopharmaceutical company’s stock after selling 1,296 shares during the period. Avantax Planning Partners Inc.’s holdings in Bristol-Myers Squibb were worth $546,000 at the end of […]
Fortem Financial Group LLC lifted its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 9.5% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 15,979 shares of the biopharmaceutical company’s stock after acquiring an additional 1,392 shares during the period. Fortem […]
Donald L. Hagan LLC decreased its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 3.0% during the 2nd quarter, Holdings Channel reports. The fund owned 25,964 shares of the biopharmaceutical company’s stock after selling 791 shares during the quarter. Bristol-Myers Squibb makes up 0.9% of Donald L. Hagan LLC’s portfolio, making the stock its […]
Nepsis Inc. increased its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 1.6% during the second quarter, according to its most recent filing with the SEC. The institutional investor owned 207,884 shares of the biopharmaceutical company’s stock after purchasing an additional 3,270 shares during the period. Bristol-Myers Squibb accounts for 4.1% of […]
Riverview Trust Co reduced its holdings in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 14.8% during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 4,573 shares of the biopharmaceutical company’s stock after selling 794 shares during the quarter. Riverview Trust Co’s holdings in Bristol-Myers […]